PMV Pharmaceuticals Inc expected to post a loss of 30 cents a share - Earnings Preview

Pmv Pharmaceuticals

09/11/2021 16:13

* PMV Pharmaceuticals Inc  PMVP.OQ   PMVP.O  is expected to show
no change in quarterly revenue when it reports  results on
November 11 (estimated). 
​* Refinitiv's mean analyst estimate for PMV Pharmaceuticals Inc
is for a loss of 30 cents per share. For the same quarter last
year, the company reported a loss of $1.46 per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for PMV
Pharmaceuticals Inc is $63​, about 60.7% above​ its last closing
price of $24.79. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2021  -0.30       -0.28      -0.29     Missed  -2.8
 Mar. 31 2021  -0.24       -0.24      -0.26     Missed  -8.3
 Dec. 31 2020              -0.57                        ​
 Sep. 30 2020  -0.34       -0.34      -1.46     Missed  -323.2
 ​​                                                     
                                                        ​
 This summary was machine generated November 9 at 16:13 GMT.  All
figures in US dollars unless otherwise stated